Evidence map›Paper›PMID 39812799›Full record

ArticleGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2025

Improvement in vision-related quality-of-life using the NEI-VFQ-9 over 1-year in the Manhattan Vision Screening and Follow-up Study (NYC-SIGHT).

Lisa A Hark, Prakash Gorroochurn, Haotian Tang, Desiree R Torres, Brendan Blackburn, Stefania C Maruri, Daniel F Diamond, Noga Harizman, Qing Wang, Yujia Wang and 4 more

Registry-linked trialAbstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04271709 (The Manhattan Vision Screening and Follow-Up Study), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04271709 naactive not recruitingnot on this map

The Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)

TypeinterventionalSponsorColumbia UniversityRan2019 to 2026Enrolled749ConditionsGlaucoma, Vision Impairment and Blindness, Cataract, Diabetic RetinopathyArmsEnhanced Intervention Using Patient Navigators, Usual Care
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Lisa A HarkDepartment of Ophthalmology, Columbia University, Vagelos College of Physicians and Surgeons, 630 W 168th Street, New York, NY, 10032, USA. lah112@cumc.columbia.edu.
Prakash GorroochurnDepartment of Biostatistics, Columbia University Mailman School of Public Health, 722 W 168th Street, New York, NY, 10032, USA.
Haotian TangDepartment of Biostatistics, Columbia University Mailman School of Public Health, 722 W 168th Street, New York, NY, 10032, USA.
Desiree R TorresEdward S. Harkness Eye Institute, Columbia University Irving Medical Center, 622 W 168th Street, PH18, New York, NY, 10032, USA.
Brendan BlackburnEdward S. Harkness Eye Institute, Columbia University Irving Medical Center, 622 W 168th Street, PH18, New York, NY, 10032, USA.
Stefania C MaruriEdward S. Harkness Eye Institute, Columbia University Irving Medical Center, 622 W 168th Street, PH18, New York, NY, 10032, USA.
Daniel F DiamondDepartment of Ophthalmology, Columbia University, Vagelos College of Physicians and Surgeons, 630 W 168th Street, New York, NY, 10032, USA.
Noga HarizmanDepartment of Ophthalmology, Columbia University, Vagelos College of Physicians and Surgeons, 630 W 168th Street, New York, NY, 10032, USA.
Qing WangDepartment of Ophthalmology, Columbia University, Vagelos College of Physicians and Surgeons, 630 W 168th Street, New York, NY, 10032, USA.
Yujia WangEdward S. Harkness Eye Institute, Columbia University Irving Medical Center, 622 W 168th Street, PH18, New York, NY, 10032, USA.
Jeffrey M LiebmannDepartment of Ophthalmology, Columbia University, Vagelos College of Physicians and Surgeons, 630 W 168th Street, New York, NY, 10032, USA.
George A CioffiDepartment of Ophthalmology, Columbia University, Vagelos College of Physicians and Surgeons, 630 W 168th Street, New York, NY, 10032, USA.
Jason D HorowitzDepartment of Ophthalmology, Columbia University, Vagelos College of Physicians and Surgeons, 630 W 168th Street, New York, NY, 10032, USA.
Lisa ParkDepartment of Ophthalmology, Columbia University, Vagelos College of Physicians and Surgeons, 630 W 168th Street, New York, NY, 10032, USA.

Funding

NCCDPHP CDC HHS U01 DP006435NCCDPHP CDC HHS U01DP006435NCCDPHP CDC HHS U01 DP006436NCCDPHP CDC HHS U01DP006436NCCDPHP CDC HHS U01 DP006892
6 · The paper itself

Abstract

purposeTo examine the nine-item National Eye Institute Vision Function Questionnaire (NEI-VFQ-9) scores at baseline and 12 months in participants enrolled in the Manhattan Vision Screening and Follow-up Study (NYC-SIGHT) and determine factors associated with improvements in vision-related quality-of-life (VRQOL).

methodsRetrospective review of NEI-VFQ-9 scores at baseline and 12-month follow-up in a community-based eye health screening study conducted in Upper Manhattan, New York. Participants were age ≥ 40 years and older, living independently in public/affordable housing developments and able to provide informed consent. Paired t-tests compared baseline and 12-month NEI-VFQ-9 composite and sub-scores and a multivariable linear regression model identified significant predictors of improvement in quality-of-life at the 95% confidence interval (CI).

resultsA total of 515 participants completed both the NEI-VFQ-9 at baseline and 12-months. Significant increases in the composite NEI-VFQ-9 score were seen with general vision, near vision tasks, and role limitation (P < 0.001). Multivariable linear regression showed that being unemployed was associated with a statistically significant increase in NEI-VFQ-9 composite score (β = 5.6, 95% CI: 0.5,10.7, P = 0.033), and the absence of ocular conditions was negatively associated with improvement in the composite score over 12 months (β = -5.4, 95% CI: -10.3, -0.5, P = 0.031).

conclusionsThese results can help researchers, clinicians, and eye health professionals better understand the factors associated with VRQOL outcomes in underserved populations utilizing the NEI-VFQ-9. Community-based vision research clinical trials can easily incorporate the NEI-VFQ-9 into baseline and follow-up instruments to assess VRQOL for future comparisons.

Indexed as

Quality of LifeVision DisordersVision ScreeningVisual AcuityAdultAgedAged, 80 and overFemaleFollow-Up StudiesHumansMaleMiddle AgedNew York CityRetrospective StudiesSurveys and QuestionnairesTime FactorsEye health screeningNational Eye Institute Vision Function Questionnaire-9NYC-SIGHTSocial determinants of healthUnderserved populationVision-related-quality-of-life (VRQOL)

Identifiers

PMID39812799

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.